ASPIRE (Arterial spin labelling Scanner- and Patient-Independent Robust Evaluation) aims to facilitate brain perfusion imaging by Magnetic Resonance Imaging (MRI) for dementia diagnosis and prognosis in clinical pharmaceutical studies and clinical practice. To establish the diagnosis of dementia - such as Alzheimer's disease (AD) - and the effect of medication on prognosis, doctors and pharmacists [...]